{"id":"W1998943227","doi":"10.1056/nejmoa0907845","title":"A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":2076,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. John’s Health Sciences Centre","funders":"Genentech; Servier; Cytokinetics; Covis Pharma; Celladon Corporation; McGill University; Boston Scientific Corporation; Daiichi Sankyo Europe; Sanofi; Biogen; GlaxoSmithKline; Louisiana Board of Regents; Bristol-Myers Squibb; AstraZeneca; Robert Wood Johnson Foundation; Amgen; Pfizer","keywords":"Medicine; Darbepoetin alfa; Kidney disease; Type 2 diabetes; Anemia; Diabetes mellitus; Internal medicine; Disease; Clinical trial; Hemoglobin; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001903931,0.0007442899,0.001720448,0.0002577161,0.0003705927,0.0007601807,0.0004936815,0.001347668,0.005376565],"category_scores_gemma":[0.00258232,0.0003178577,0.001041065,0.0003284437,0.0005172052,0.0005789389,0.0004119022,0.002524484,0.000459432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000379007,"about_ca_system_score_gemma":0.0007991029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000462535,"about_ca_topic_score_gemma":0.0007355385,"domain_scores_codex":[0.9991332,0.0005662844,0.00005438785,0.0001141919,0.00007400431,0.00005794318],"domain_scores_gemma":[0.9987307,0.0005115658,0.0002468659,0.00007159085,0.0000602802,0.0003790641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9653285,0.002438698,0.001227873,0.0009172171,0.001280761,0.00007898016,0.00004534641,0.0002425202,0.001460896,0.0002346568,0.001681965,0.02506264],"study_design_scores_gemma":[0.9791717,0.01658755,0.002163006,0.00005744171,0.0003147824,0.00005129623,0.000009965028,0.0001740831,0.0000863614,0.0001517654,0.001227014,0.00000494124],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9577655,0.02669654,0.0006019988,0.002917059,0.001976502,0.002708978,0.001334067,0.00007287962,0.005926541],"genre_scores_gemma":[0.979062,0.007309765,0.001291086,0.003155362,0.001273406,0.003731064,0.001249108,0.00001375533,0.002914438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005376565,"threshold_uncertainty_score":0.01798642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01367268627852847,"score_gpt":0.284810498852715,"score_spread":0.2711378125741866,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}